Clinical Trial Update: A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO). [NA]

View source ↗

Summary

This completed prospective, non-randomized study evaluated the safety and performance of the NovaCross Microcatheter for femoropopliteal chronic total occlusion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Total Occlusion

Drugs mentioned

• NovaCross Microcatheter

Snippet

Sponsor: Nitiloop Ltd. | Conditions: Chronic Total Occlusion | NA | Status: COMPLETED